6.
Nguyen A, Wang K, Hu G, Wang X, Miao Z, Azevedo J
. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease. Acta Neuropathol. 2020; 140(4):477-493.
PMC: 7520051.
DOI: 10.1007/s00401-020-02200-3.
View
7.
Sjoblom N, Boyd S, Manninen A, Knuuttila A, Blom S, Farkkila M
. Chronic cholestasis detection by a novel tool: automated analysis of cytokeratin 7-stained liver specimens. Diagn Pathol. 2021; 16(1):41.
PMC: 8101247.
DOI: 10.1186/s13000-021-01102-6.
View
8.
Fasano A, Espay A, Tang-Wai D, Wikkelso C, Krauss J
. Gaps, Controversies, and Proposed Roadmap for Research in Normal Pressure Hydrocephalus. Mov Disord. 2020; 35(11):1945-1954.
DOI: 10.1002/mds.28251.
View
9.
Graff-Radford N
. Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology. 2014; 83(17):1573-5.
PMC: 4222848.
DOI: 10.1212/WNL.0000000000000916.
View
10.
Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N
. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436.
PMC: 9005347.
DOI: 10.1038/s41588-022-01024-z.
View
11.
ElObeid A, Laurell K, Cesarini K, Alafuzoff I
. Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus. J Neuropathol Exp Neurol. 2015; 74(5):470-9.
DOI: 10.1097/NEN.0000000000000191.
View
12.
Jack Jr C, Therneau T, Weigand S, Wiste H, Knopman D, Vemuri P
. Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework. JAMA Neurol. 2019; 76(10):1174-1183.
PMC: 6632154.
DOI: 10.1001/jamaneurol.2019.1971.
View
13.
Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I
. The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques. Cell Rep. 2019; 27(4):1293-1306.e6.
PMC: 7340153.
DOI: 10.1016/j.celrep.2019.03.099.
View
14.
Dubois B, Feldman H, Jacova C, DeKosky S, Barberger-Gateau P, Cummings J
. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6(8):734-46.
DOI: 10.1016/S1474-4422(07)70178-3.
View
15.
Sachdev P, Blacker D, Blazer D, Ganguli M, Jeste D, Paulsen J
. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol. 2014; 10(11):634-42.
DOI: 10.1038/nrneurol.2014.181.
View
16.
Wikkelso C, Hellstrom P, Klinge P, Tans J
. The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2012; 84(5):562-8.
DOI: 10.1136/jnnp-2012-303314.
View
17.
Sun N, Victor M, Park Y, Xiong X, Scannail A, Leary N
. Human microglial state dynamics in Alzheimer's disease progression. Cell. 2023; 186(20):4386-4403.e29.
PMC: 10644954.
DOI: 10.1016/j.cell.2023.08.037.
View
18.
Wang Y, Ulland T, Ulrich J, Song W, Tzaferis J, Hole J
. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016; 213(5):667-75.
PMC: 4854736.
DOI: 10.1084/jem.20151948.
View
19.
Munoz-Castro C, Mejias-Ortega M, Sanchez-Mejias E, Navarro V, Trujillo-Estrada L, Jimenez S
. Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer's disease hippocampus. Acta Neuropathol Commun. 2023; 11(1):31.
PMC: 9976401.
DOI: 10.1186/s40478-023-01530-z.
View
20.
Espay A, Da Prat G, Dwivedi A, Rodriguez-Porcel F, Vaughan J, Rosso M
. Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration. Ann Neurol. 2017; 82(4):503-513.
DOI: 10.1002/ana.25046.
View